Our company is dedicated to translational research initiatives that will advance diagnostics and evaluation of eye and systemic disease. Our primary focus is to provide an objective measurement of tear fluid biomarkers to standardize treatment solutions not only for dry eye but for systemic disease. We are an innovative tear fluid analytic company enabling detection of hard to diagnose diseases by collecting and analyzing tear fluid in a non-invasive way.